litlas
ログインアカウント作成

Gary J. Schiller

1992–2025 年に発表

130
論文数
18,441
被引用数
70
h 指数
121
i10 指数

被引用数

Gary J. Schiller の年別被引用数1948 年: 被引用 2 件1984 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 3 件1995 年: 被引用 5 件1996 年: 被引用 10 件1997 年: 被引用 19 件1998 年: 被引用 46 件1999 年: 被引用 41 件2000 年: 被引用 31 件2001 年: 被引用 37 件2002 年: 被引用 52 件2003 年: 被引用 54 件2004 年: 被引用 56 件2005 年: 被引用 49 件2006 年: 被引用 77 件2007 年: 被引用 81 件2008 年: 被引用 77 件2009 年: 被引用 69 件2010 年: 被引用 87 件2011 年: 被引用 70 件2012 年: 被引用 81 件2013 年: 被引用 87 件2014 年: 被引用 84 件2015 年: 被引用 107 件2016 年: 被引用 123 件2017 年: 被引用 155 件2018 年: 被引用 159 件2019 年: 被引用 614 件2020 年: 被引用 679 件2021 年: 被引用 690 件2022 年: 被引用 587 件2023 年: 被引用 525 件2024 年: 被引用 841 件2025 年: 被引用 441 件2026 年: 被引用 5 件1949〜1983 年は被引用が無いため表示していません1985〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,700 件、この内訳の 30.5%ドイツ: 引用元論文 648 件、この内訳の 7.3%中国: 引用元論文 576 件、この内訳の 6.5%イタリア: 引用元論文 545 件、この内訳の 6.1%フランス: 引用元論文 501 件、この内訳の 5.6%イギリス: 引用元論文 484 件、この内訳の 5.5%スペイン: 引用元論文 286 件、この内訳の 3.2%カナダ: 引用元論文 284 件、この内訳の 3.2%オランダ: 引用元論文 257 件、この内訳の 2.9%オーストラリア: 引用元論文 239 件、この内訳の 2.7%スイス: 引用元論文 179 件、この内訳の 2%日本: 引用元論文 157 件、この内訳の 1.8%
0%30.5%その他 22.7%

機関

分野

  • Medicine80.3%
  • Biochemistry, Genetics and Molecular Biology13%
  • Immunology and Microbiology2.9%
  • Materials Science1.8%
  • Engineering0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • その他1.4%

トピック

  • Acute Myeloid Leukemia Research9.3%
  • CAR-T cell therapy research6.9%
  • Acute Lymphoblastic Leukemia research4%
  • Hematopoietic Stem Cell Transplantation3.7%
  • Chronic Myeloid Leukemia Treatments3.5%
  • Multiple Myeloma Research and Treatments3.4%
  • その他69.2%

共著者

全論文

検索で開く
  1. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

    著者: Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Chaoling Feng, Jinghui Dong, Tong Shen, Francesca Milletti, John M. Rossi, Remus Vezan, Behzad Kharabi Masouleh, Roch Houot - The Lancet 2021 被引用: 769

  2. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

    著者: Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Richard M. Stone, Dale L. Bixby, Jonathan E. Kolitz, Gary J. Schiller, Matthew J. Wieduwilt, Daniel H. Ryan, Antje Hoering, Kamalika Banerjee, Michael Chiarella, Arthur C. Louie, Bruno C. Medeiros - Journal of Clinical Oncology 2018 被引用: 990

  3. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

    著者: Max S. Topp, Nicola Gökbuget, Anthony S. Stein, Gerhard Zugmaier, Susan O’Brien, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard T. Heffner, Richard A Larson, Svenja Neumann, Robin Foà, Mark R. Litzow, Josep‐María Ribera, Alessandro Rambaldi, Gary J. Schiller, Monika Brüggemann, Heinz A. Horst, Chris Holland, Catherine Jia, Tapan Maniar, Birgit Huber, Dirk Nagorsen, Stephen J. Forman, Hagop M. Kantarjian - The Lancet Oncology 2014 被引用: 1,259

  4. Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia

    著者: Naval Daver, Alexander E. Perl, Joseph Maly, Mark J. Levis, Ellen K. Ritchie, Mark R. Litzow, James McCloskey, Catherine C. Smith, Gary J. Schiller, Terrence Bradley, Ramón V. Tiu, Kiran Naqvi, Monique Dail, Deanna J. Brackman, Satya R. Siddani, Jing Wang, Brenda Chyla, Paul Lee, Jessica K. Altman - Journal of Clinical Oncology 2022 被引用: 187

  5. Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

    著者: Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew J. Yee, Carol Ann Huff, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, Meletios Α. Dimopoulos, A. Keith Stewart, Joshua Richter, Ravi Vij, Sascha A. Tuchman, Marc S. Raab, Katja Weisel, Michel Delforge, Robert F. Cornell, David Kaminetzky, James E. Hoffman, Luciano J. Costa, Terri L. Parker, Moshe Levy, Martin Schreder, Nathalie Meuleman, Laurent Frenzel, Mohamad Mohty, Sylvain Choquet, Gary J. Schiller, Raymond L. Comenzo, Monika Engelhardt, Thomas Illmer, Philip Vlummens, Chantal Doyen, Thierry Façon, Lionel Karlin, Aurore Perrot, Klaus Podar, Michael Kauffman, Sharon Shacham, Lingling Li, Shijie Tang, Carla Picklesimer, Jean‐Richard Saint‐Martin, Marsha Crochiere, Hua Chang, Samir Parekh, Yosef Landesman, Jatin J. Shah, Paul G. Richardson, Sundar Jagannath - New England Journal of Medicine 2019 被引用: 673

  6. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

    著者: Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski, John E.J. Rasko, Jean‐Antoine Ribeil, Suradej Hongeng, Elisa Magrin, Gary J. Schiller, Emmanuel Payen, Michaëla Semeraro, Despina Moshous, François Lefrère, Hervé Puy, Philippe Bourget, Alessandra Magnani, Laure Caccavelli, Jean‐Sébastien Diana, Felipe Suarez, Fabrice Monpoux, Valentine Brousse, Catherine Poirot, Chantal Brouzes, Jean–François Méritet, Corinne Pondarré, Yves Beuzard, Stany Chrétien, Thibaud Lefèbvre, David T. Teachey, Usanarat Anurathapan, P. Joy Ho, Christof von Kalle, Morris Kletzel, Elliott Vichinsky, Sandeep Soni, Gábor Veres, Olivier Nègre, Robert W. Ross, David Davidson, Alexandria Petrusich, Laura Sandler, Mohammed Asmal, Olivier Hermine, Mariane De Montalembert, Salima Hacein‐Bey‐Abina, Stéphane Blanche, Philippe Leboulch, Marina Cavazzana - New England Journal of Medicine 2018 被引用: 661

  7. KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

    著者: Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole, Aaron C. Logan, Maria R. Baer, William B. Donnellan, Kristen M. O’Dwyer, Houston Holmes, Martha Arellano, Armin Ghobadi, John M. Pagel, Yi Lin, Ryan D. Cassaday, Jae H. Park, Mehrdad Abedi, Januario E. Castro, Daniel J. DeAngelo, Adriana K. Malone, Raya Mawad, Gary J. Schiller, John M. Rossi, Adrian Bot, Tong Shen, Lovely Goyal, Rajul K. Jain, Remus Vezan, William G. Wierda - Blood 2021 被引用: 200

  8. CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

    著者: Sarah Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Melanie Ayala Ceja, Martin Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven de Vos, Patricia A. Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, Yvonne Y. Chen - Cancer Discovery 2022 被引用: 101

  9. Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

    著者: Justin M. Watts, Maria R. Baer, Jay Yang, Thomas Prébet, Sang‐Min Lee, Gary J. Schiller, Shira Dinner, Arnaud Pigneux, Pau Montesinos, Eunice S. Wang, Karen Seiter, Andrew H. Wei, Stéphane de Botton, Montserrat Arnán, Will Donnellan, Anthony P. Schwarer, Christian Récher, Brian A. Jonas, P. Brent Ferrell, Christophe Marzac, Patrick Kelly, Jennifer Sweeney, Sanjeev Forsyth, Sylvie M. Guichard, Julie Brevard, Patrick Henrick, Hesham Mohamed, Jörge E. Cortes - The Lancet Haematology 2022 被引用: 117

  10. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

    著者: Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Dale L. Bixby, Jonathan E. Kolitz, Gary J. Schiller, Matthew J. Wieduwilt, Daniel Ryan, Stefan Faderl, Jörge E. Cortes - The Lancet Haematology 2021 被引用: 211

  11. Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial

    著者: Eunice S. Wang, Ghayas C. Issa, Harry P. Erba, Jessica K. Altman, Pau Montesinos, Stephane DeBotton, Roland B. Walter, Kristen Pettit, Michael R. Savona, Mithun Vinod Shah, Marina Kremyanskaya, Maria R. Baer, James M. Foran, Gary J. Schiller, Lionel Adès, Maël Heiblig, Céline Berthon, Pierre Péterlin, Eduardo Rodríguez‐Arbolí, Olga Salamero, Mrinal M. Patnaik, Cristina Papayannidis, Jolanta Grembecka, Tomasz Cierpicki, Bradley Clegg, Joshua Ray, Brian M. Linhares, Kun Nie, Amitava Mitra, Julie Mackey Ahsan, Marilyn Tabachri, Harris S. Soifer, Daniel Corum, Mollie Leoni, Stephen Dale, Amir T. Fathi - The Lancet Oncology 2024 被引用: 95

  12. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    著者: Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes, Catherine C. Smith, Mark R. Litzow, Maria R. Baer, David F. Claxton, Harry P. Erba, Stan Gill, Stuart L. Goldberg, Joseph G. Jurcic, Richard A Larson, Chaofeng Liu, Ellen K. Ritchie, Gary J. Schiller, Alexander I. Spira, Stephen A. Strickland, Raoul Tibes, Celalettin Üstün, Eunice S. Wang, Robert K. Stuart, Christoph Röllig, Andreas Neubauer, Giovanni Martinelli, Erkut Bahceci, Mark J. Levis - The Lancet Oncology 2017 被引用: 488

  13. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

    著者: Amy Burd, Ross L. Levine, Amy S. Ruppert, Alice S. Mims, Uma Borate, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael W. Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, James M. Foran, Tara L. Lin, Brian Ball, Michael Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Jo-Anne Vergilio, Timothy J. Brennan, Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 被引用: 192

  14. Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

    著者: Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee‐Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Mark J. Levis - Blood 2022 被引用: 137

  15. Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

    著者: Harry P. Erba, Amir T. Fathi, Ghayas C. Issa, Jessica K. Altman, Pau Montesinos, Mrinal M. Patnaik, James M. Foran, Stéphane de Botton, Maria R. Baer, Gary J. Schiller, Roland B. Walter, Marina Kremyanskaya, Kristen Pettit, Stephen A. Strickland, Blake Tomkinson, Marilyn Tabachri, Mollie Leoni, Stephen Dale, Eunice S. Wang - Blood 2022 被引用: 71

  16. Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

    著者: Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotić, Loree Larratt, Fritz Offner, Gary J. Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjørn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stéphane Leprêtre, Frédéric Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham H. Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles - Leukemia 2018 被引用: 247

  17. Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

    著者: Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot - Journal of Hematology & Oncology 2022 被引用: 76

  18. Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML

    著者: Keith W. Pratz, Mohamad Cherry, Jessica K. Altman, Brenda Cooper, Nikolai A. Podoltsev, José C. Cruz, Tara L. Lin, Gary J. Schiller, Joseph G. Jurcic, Adam Asch, Ruishan Wu, Jason E. Hill, Stanley C. Gill, Angela James, Elizabeth Rich, Nahla Hasabou, Alexander E. Perl, Mark J. Levis - Journal of Clinical Oncology 2023 被引用: 46

  19. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

    著者: Elizabeta Nemeth, Erika V. Valore, Mary Territo, Gary J. Schiller, Alan Lichtenstein, Tomas Ganz - Blood 2003 被引用: 1,411

  20. Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3

    著者: Thomas Fischer, Richard M. Stone, Daniel J. DeAngelo, Ilene Galinsky, Elihu H. Estey, Carlo Lanza, Edward Fox, Gerhard Ehninger, Eric J. Feldman, Gary J. Schiller, Virginia M. Klimek, Stephen D. Nimer, D. Gary Gilliland, Catherine Dutreix, Alice Huntsman-Labed, J. D. Virkus, Francis J. Giles - Journal of Clinical Oncology 2010 被引用: 502

  21. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

    著者: Mitchell E. Horwitz, Patrick J. Stiff, Corey Cutler, Claudio G. Brunstein, Rabi Hanna, Richard T. Maziarz, Andrew R. Rezvani, Nicole A. Karris, Joseph P. McGuirk, David Valcárcel, Gary J. Schiller, Caroline A. Lindemans, William Ying Khee Hwang, Liang Piu Koh, Amy K. Keating, Yasser Khaled, Nelson Hamerschlak, Olga Frankfurt, Tony Peled, Irit Segalovich, Beth Blackwell, Stephen Wease, Laurence S. Freedman, Einat Galamidi-Cohen, Guillermo Sanz - Blood 2021 被引用: 110

  22. Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors

    著者: Anthony S. Stein, Gary J. Schiller, Ramsis Benjamin, Catherine Jia, Alicia Zhang, Min Zhu, Zachary Zimmerman, Max S. Topp - Annals of Hematology 2018 被引用: 104

  23. A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    著者: Amer M. Zeidan, Maya Ridinger, Tara L. Lin, Pamela S. Becker, Gary J. Schiller, Prapti A. Patel, Alexander I. Spira, Michaela L. Tsai, Errin Samuëlsz, Sandra Silberman, Mark G. Erlander, Eunice S. Wang - Clinical Cancer Research 2020 被引用: 89

  24. Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study

    著者: Jeffrey E. Lancet, Farhad Ravandi, Pau Montesinos, Jacqueline C. Barrientos, Talha Badar, Adrían Alegre, Asad Bashey, Juan Miguel Bergua Burgués, Lorenzo Brunetti, Emily Curran, David C. Christian de Leeuw, Enrico Derenzini, Geert A. Huls, Jeroen J. W. M. Janssen, Deepa Jeyakumar, Mojca Jongen‐Lavrencic, Ashwin Kishtagari, María‐Victoria Mateos, Daniel Morillo, Alessandro Rambaldi, Aaron S. Rosenberg, Gary J. Schiller, Uzma Ahmed, Alexandru Cacovean, Stephan W. Morris, Courtney A. Follit, Brian Munneke, Ganesh Waghmare, Clarissa Mandap, Mona Vimal, Thomas W. Butler, Hetty E. Carraway - Blood 2023 被引用: 30